Federal Register of Legislation - Australian Government

Primary content

No. 91 of 2011 Determinations/Veterans' Entitlements as made
Amendment of Statement of Principles concerning malignant neoplasm of the endometrium.
Administered by: Veterans' Affairs
Registered 08 Jul 2011
Tabling HistoryDate
Tabled HR16-Aug-2011
Tabled Senate18-Aug-2011
Date of repeal 19 Mar 2014
Repealed by Veterans' Affairs (Spent and Redundant Instruments) Repeal Regulation 2014

 

Amendment Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF the endometrium

No. 91 of 2011

 

for the purposes of the

 

Veterans’ Entitlements Act 1986

and

Military Rehabilitation and Compensation Act 2004

 

1.                     This Instrument may be cited as Statement of Principles concerning malignant neoplasm of the endometrium No. 91 of 2011.

 

2.                     The Repatriation Medical Authority amends, under subsection 196B(8) of the Veterans’ Entitlements Act 1986, Statement of Principles concerning malignant neoplasm of the endometrium Instrument No. 99 of 2007 by:

 

(A)             Deleting existing factor "(e)" concerning 'therapeutic radiation' from clause 6;

 

(B)              Re-numbering existing factors "(f)" to "(h)" in clause 6 as "(e)" to "(g)" respectively;

 

(C)              Replacing "6(h)" in clause 7 with "6(g)"; and

 

(D)             Deleting the definition of "a course of therapeutic radiation" from clause 9.

 

3.                     The amendment made by this instrument applies to all matters to which Instrument No. 99 of 2007, section 120A of the Veterans’ Entitlements Act 1986 and section 338 of the Military Rehabilitation and Compensation Act 2004 apply.

 

4.                     The amendment made by this instrument takes effect from 13 July 2011.

 

Dated this   first   day of   July   2011

 

 

The Common Seal of the                    )

Repatriation Medical Authority          )

was affixed to this instrument                        )

in the presence of:                               )

 

KEN DONALD

CHAIRPERSON